Rockwell Medical, Inc. (RMTI)

Rockwell Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	40	66	54	12	39	95
Market Cap Growth	-41.32%	22.44%	356.04%	-69.35%	-59.24%	-39.44%
Enterprise Value	32	62	57	7	35	50
Last Close Price	1.09	2.04	1.89	1.01	4.51	11.11
PS Ratio	0.50	0.65	0.64	0.16	0.62	1.52
PB Ratio	1.16	2.02	2.53	0.84	15.20	2.77
P/TBV Ratio	1.63	3.07	5.60	0.90	23.87	2.84
P/FCF Ratio	-	20.66	-	-	-	-
P/OCF Ratio	-	15.69	-	-	-	-
EV/Sales Ratio	0.43	0.61	0.68	0.09	0.56	0.81
EV/EBITDA Ratio	-	22.18	-	-	-	-
EV/EBIT Ratio	-	101.70	-	-	-	-
EV/FCF Ratio	-	19.38	-	-	-	-
Debt / Equity Ratio	0.36	0.42	0.63	1.16	11.40	0.70
Debt / EBITDA Ratio	-	2.75	-	-	-	-
Debt / FCF Ratio	-	4.24	-	-	-	-
Asset Turnover	1.32	1.82	1.69	1.53	0.98	1.02
Inventory Turnover	13.02	14.42	12.82	13.90	16.11	15.73
Quick Ratio	3.34	2.12	1.31	1.57	1.35	4.91
Current Ratio	3.92	2.63	1.73	2.00	1.68	5.43
Return on Equity (ROE)	-16.68%	-1.78%	-47.68%	-224.49%	-178.04%	-113.38%
Return on Assets (ROA)	-5.25%	0.68%	-8.44%	-22.03%	-30.02%	-29.10%
Return on Capital Employed (ROCE)	-10.00%	1.30%	-18.80%	-58.00%	-109.90%	-43.80%
Earnings Yield	-13.81%	-0.73%	-15.67%	-158.20%	-84.81%	-32.68%
FCF Yield	-6.84%	4.84%	-18.01%	-145.76%	-88.40%	-32.47%
Buyback Yield / Dilution	-14.40%	-33.17%	-63.05%	-67.77%	-24.02%	-24.14%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q